Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Bionano Genomics, Inc. (BNGO) had Pre-Tax Income of $-7.42M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$8.17M |
|
$-7.42M |
|
$3.86M |
|
$4.31M |
|
$15.39M |
|
$-7.22M |
|
$-0.20M |
|
|
Pre-Tax Income |
$-7.42M |
$-7.42M |
|
$-7.42M |
|
$-7.42M |
|
$-7.42M |
|
$-7.42M |
|
$-7.22M |
|
$-4.98M |
|
11.55M |
|
11.55M |
|
$-0.64 |
|
$-0.64 |
|
| Balance Sheet Financials | |
$24.88M |
|
$13.02M |
|
$22.71M |
|
$47.59M |
|
$10.04M |
|
$3.44M |
|
$5.95M |
|
$15.98M |
|
$31.61M |
|
$29.94M |
|
$31.61M |
|
11.78M |
|
| Cash Flow Statement Financials | |
$-10.39M |
|
$19.14M |
|
$-9.04M |
|
$4.51M |
|
$4.23M |
|
$-0.28M |
|
$1.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.48 |
|
-- |
|
-- |
|
0.10 |
|
0.12 |
|
52.80% |
|
-88.34% |
|
-88.34% |
|
-- |
|
-90.76% |
|
-90.85% |
|
$-10.39M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.74 |
|
1.87 |
|
48.09 |
|
-23.49% |
|
-24.79% |
|
-15.60% |
|
-21.18% |
|
$2.68 |
|
$-0.90 |
|
$-0.90 |
|